Abstract:Cyclic nucleotides are important signaling molecules that play many critical physiological roles including controlling cell fate and development, regulation of metabolic processes, and responding to changes in the environment. Cyclic nucleotides are also pivotal regulators in immune signaling, orchestrating intricate processes that maintain homeostasis and defend against pathogenic threats. This review provides a comprehensive examination of the pharmacological potential of cyclic nucleotide signaling pathways within the realm of immunity. Beginning with an overview of the fundamental roles of cAMP and cGMP as ubiquitous second messengers, this review delves into the complexities of their involvement in immune responses. Special attention is given to the challenges associated with modulating these signaling pathways for therapeutic purposes, emphasizing the necessity for achieving cell-type specificity to avert unintended consequences. A major focus of the review is on the recent paradigm-shifting discoveries regarding specialized cyclic nucleotide signals in the innate immune system, notably the cGAS–STING pathway. The significance of cyclic dinucleotides, exemplified by 2′3′-cGAMP, in controlling immune responses against pathogens and cancer, is explored. The evolutionarily conserved nature of cyclic dinucleotides as antiviral agents, spanning across diverse organisms, underscores their potential as targets for innovative immunotherapies. Findings from the last several years have revealed a striking diversity of novel bacterial cyclic nucleotide second messengers which are involved in antiviral responses. Knowledge of the existence and precise identity of these molecules coupled with accurate descriptions of their associated immune defense pathways will be essential to the future development of novel antibacterial therapeutic strategies. The insights presented herein may help researchers navigate the evolving landscape of immunopharmacology as it pertains to cyclic nucleotides and point toward new avenues or lines of thinking about development of therapeutics against the pathways they regulate.

Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING

Distinct Dynamical and Conformational Features of Human STING in Response to 2'3'-cGAMP and c-di-GMP.

A Novel Transcript Isoform of STING That Sequesters Cgamp and Dominantly Inhibits Innate Nucleic Acid Sensing

Design, Synthesis and Biological Evaluation of (2′,5′ and 3′5′-Linked) cGAMP Analogs that Activate Stimulator of Interferon Genes (STING)

Exploration of the Binding Mechanism of Cyclic Dinucleotide Analogs to Stimulating Factor Proteins and the Implications for Subsequent Analog Drug Design

Arabinose- and xylose-modified analogs of 2',3'-cGAMP act as STING agonists

Progress on the Synthesis and Activity of Cyclic Dinucleotides As Stimulator of Interferon Gene (STING) Agonists

TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN

The role of cGAMP via the STING pathway in modulating germinal center responses and CD4 T cell differentiation

Stimulator of Interferon Genes in Classical Dendritic Cells Controls Mucosal Th17 Responses to Cyclic Dinucleotides for Host Defenses Against Microbial Infections in Gut.

Pharmacological potential of cyclic nucleotide signaling in immunity

Detection of Cyclic Dinucleotides by STING.

Agonists and Inhibitors of the STING Pathway: Potential Agents for Immunotherapy

DNA-PK controls cyclic dinucleotide-associated type I Interferon responses

Structure of STING Bound to Cyclic Di-Gmp Reveals the Mechanism of Cyclic Dinucleotide Recognition by the Immune System

Agonists and Inhibitors of the Cgas-Sting Pathway

The Mechanism of Double-Stranded DNA Sensing Through the Cgas-Sting Pathway.

Design and syntheses of a bimolecular STING agonist based on the covalent STING antagonist

Cyclopeptide Inhibitors Target the N‐Terminal Tail of STING and Alleviate Autoinflammation

Synthesis and biological evaluation of all possible inosine-mixed cyclic dinucleotides that activate different hSTING variants

Proteomic and phosphoproteomic analyses of Jurkat T-cell treated with 2'3' cGAMP reveals various signaling axes impacted by cyclic dinucleotides